Walter Reed Vaccine Shows 89 Percent Efficacy Against Shigellosis
An experimental vaccine developed by the Walter Reed Army Institute of Research achieved 89% efficacy in preventing shigellosis during a clinical trial published in The Lancet Infectious Diseases, offering a potential breakthrough against a leading global cause of severe childhood diarrheal disease and antibiotic resistance. Diarrhea remains an enduring public health crisis globally, claiming more … Read more